Posted on 8 月 9, 20218/9/21
CMS Releases Remote Therapeutic Monitoring Codes for 2022
Posted on 8 月 6, 20218/6/21
BLOG: ‘Bundling’ Payments to Assure Appropriate Rx Use
Posted on 7 月 30, 20217/30/21
Competitive Benchmarking In Trade – Answering The Who, What, Why and When
Posted on 7 月 26, 20217/26/21
Breaking through Barriers: Critical Success Factors for Launching Products with Breakthrough Therapy Designation
Posted on 7 月 20, 20217/20/21
BLOG: Pharmaceutical Value-based Contracts: Adherence and Supportive Contracts
Posted on 7 月 13, 20217/13/21
Case Study: Launching a New Therapy for HER2-Positive Metastatic Breast Cancer
Posted on 7 月 13, 20217/13/21
The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making
Posted on 7 月 1, 20217/1/21
BLOG: Medical vs. Pharmacy Benefit: A Look at UM Differences
Posted on 6 月 29, 20216/29/21
Next Gen Commercialization: Accelerating Patient Access to Life-Changing Therapies
Posted on 6 月 15, 20216/15/21